Somatotropic axis and ageing;Fonction somatotrope et vieillissement

Nutrition Clinique et Metabolisme

Volumn 14, Issue 1, 2000, Pages 5-23

  Noël, Michèle ^a   Coudray Lucas, Colette ^b,c   Porquet, Dominique ^a   Lesourd, Bruno ^d  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL CHARLES FOIX   (France)

Author keywords

Growth hormone; Immune system; Insulin like growth factor I; Replacement therapy

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

AGING; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE METABOLISM; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS; IMMOBILIZATION; IMMUNE SYSTEM; LEAN BODY WEIGHT; METABOLISM; OBESITY; REVIEW;

EID: 0034057466     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0985-0562(00)80036-9     Document Type: Review

References (159)

1. De Bandt JP, Blondé-Cynober F, Bories PH, Cassereau C, Cynober L, Devanlay M, et al. Les modifications de la sensibilité aux hormones au cours du vieillissement : conséquences métaboliques et nutritionnelles. Nutr Clin Métabol 1998 ; 12 : 161-86.
2. Li CH, Evans HM, Simpson ME. Isolation and properties of the anterior hypophysial growth hormone. J Biol Chem 1945 ; 159 : 353-6.
3. Finkelstein J, Rolfworg H, Bayer R, Kream J, Hellman L. Age related changes in the twenty-four hours spontaneous secretion of growth hormone. J Clin Endocrinol Metab 1972 ; 35 : 665-70.
4. Winer LM, Shaw MA, Bauman G. Basal plasma growth hormone levels in man: new evidence for rythmicity of growth hormone secretion. J Clin Endocrinol Metab 1990 ; 70 : 1678-86.
5. Ling N, Esch F, Bohlen P, Brazeau P, Wehrenberg WB, Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Nat Acad Sci USA 1984 ; 81 : 4302-6.
6. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973 ; 179 : 77-9.
7. Leung DW, Spencer SA, Cachianes G, Hamonds RG, Collins C, Henzel WJ, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987 ; 330 : 537-43.
8. Baumann G, Mercado M. Growth hormone-binding proteins in plasma. Nutrition 1993 ; 9 : 546-53.
9. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Rev 1989 ; 10 : 68-91.
10. Humbel E. Insulin-like growth factors I and II. Eur J Biochem 1990 ; 190 : 445-62.
11. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993 ; 55 : 131-83.
12. Porquet D. IGF-I: métabolisme et action physiologique. Nutr Clin Metab 1996 ; 10 : 253-64.
13. Berelowitz M, Szabo M, Frohman LA, Firoslone S, Cha L, Hintz RL. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981 ; 212 : 1279-81.
14. Sara VR, Hall K. Insulin-like growth factow and their binding proteins. Physiol Rev 1990 ; 70 : 591-614.
15. Rechler MM. Insulin-like growth factors binding proteins. Vitam Horm 1993 ; 47 : 1-114.
16. Rechler MM, Brown AL. Insulin-like growth factor binding proteins: gene structure and expression. Growth Regul 1992 ; 2 : 55-68.
17. Baxter RC. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol Metab 1993 ; 4 : 91-6.
18. Baxter RC. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 1994 ; 42 : 140-4.
19. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev 1995 ; 16 : 3-34.
20. Werner H, Woloschak M, Stannard B, Shen-Orr Z, Roberts Jr CT, LeRoith D. The insulin-like growth factor I receptor: molecular biology, heterogeneity, and regulation. In: LeRoith D, ed. Insulin-like growth factors: molecular and cellular aspects. Boca Raton : CRC Press ; 1991. p. 17-47.
21. Vance ML, Hartman ML, Thorner MO. Growth hormone and nutrition. Horm Res 1992 ; 38 : 85-8.
22. Valk NK, Lely AJ, De Herder WW, Lindemans J, Lamberts SWJ. The effects of human growth hormone (GH) administration in GH-deficient adults: a 20 day metabolic ward study. J Clin Endocrinol Metab 1994 ; 79 : 1070-5.
23. Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, et al. Comparison of the effects of growth hormone and insulin-like growth factor 1 on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 1994 ; 94 : 1126-33.
24. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990 ; 86 : 265-72.
25. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thomason M, Umpleby AM, et al. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol 1993 ; 38 : 427-31.
26. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebaek NE, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989 ; 339 : 1221-5.
27. Richelsen B. Action of growth hormone in adipose tissue. Horm Res 1997 ; 48 suppl 5 : 105-10.
28. Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989 ; 321 : 1797-803.
29. Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, et al. Comparison of the effects of growth hormone and insulin-like growth factor 1 on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 1994 ; 94 : 1126-33.
30. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, et al. Insulin-like growth factor 1 stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 1993 ; 92 : 2249-56.
31. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 1993 ; 91 : 391-6.
32. Turkalj I, Keller U, Ninnis R, Vosmeet S, Stauffacher W. Effect of increasing doses of recombinant human insulin-like growth factor 1 on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab 1992 ; 75 : 1186-91.
33. Guler HP, Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor 1 in healthy adults. N Engl J Med 1987 ; 217 : 137-40.
34. Zenobi PD, Graf S, Ursprung H, Froesch ER. Effects of insulin-like growth factor 1 on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 1992 ; 89 : 1908-13.
35. Clemmons DR, Smith-Banks A, Underwood LE. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor 1 in humans. J Clin Endocrinol Metab 1992 ; 75 : 234-8.
36. Mauras N, Horber FF, Haymond MW. Low dose recombinant human insulin-like growth factor 1 fails to affect protein anabolism but inhibits islet cell secretion in human. J Clin Endocrinol Metab 1992 ; 75 : 1192-7.
37. Boulware SD, Tambourlane WV, Mathews LS, Sherwin RS. Diverse effects of insulin-like growth factor 1 on glucose, lipid, and amino acids. Am J Physiol 1992 ; 262 : E130-3.
38. Shernin RS, Borg WP, Boulware SD. Metabolic effects of insulin-like growth factor I in normal humans. Horm Res 1994 ; 41 suppl 2 : 97-102.
39. Auernhammer CJ, Strasburger CJ. Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol 1995 ; 133 : 635-45.
40. Kooijman R, Hooghe-Peters EL, Hooghe R. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system. Adv Immunol 1996 ; 63 : 377-454.
41. Hattori N, Shimatsu A, Sugita M, Kumagai S, Imura H. Immunoreactive growth hormone (5GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem Biophys Res Commun 1990 ; 168 : 396-401.
42. Varma S, Sabharwal P, Sheridan JF, Malarkey WB. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. Endocrinol Metab 1993 ; 76 : 49-53.
43. Valtora A, Moretta A, Maccario R, Bozzola M, Severi F. Infuence of growth hormone-releasing hormone (GHRH) on phytohemagglutinin-induced lymphocyte activation: comparison of two synthetic forms. Thymus 1991 ; 18 : 51-9.
44. Hattori N, Shimomura K, Ishihara T, Moridera K, Hino M, Ikekubo, et al. Growth hormone (GH) secretion from human lymphocytes is up-regulated by GH, but not affected by insulin-like growth factor-I. J Endocrinol Metab 1993 ; 76 : 937-9.
45. Gala R, Shevach EM. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 1993 ; 133 : 1617-23.
46. Viselli SM, Mastro AM. Prolactin receptors are found on heterogenous subpopulations of rat splenocytes. Endocrinology 1993 ; 132 : 571-6.
47. Stuart CA, Meehan RT, Neale LS, Cintron NM, Furlanetto RW. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab 1991 ; 72 : 1117-22.
48. Kooijnan R, Willems M, De Haas CJ, Rijckers GT, Schuurmans AL, Van Buul-Offers SC, et al. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 1992 ; 131 : 2244-50.
49. Kozak RW, Haskell JF, Greenstein LA, Rechler MM, Waldmann TA, Nissley SP. Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T-lymphocytes. Cell Immun 1987 ; 109 : 318-31.
50. Merchav S, Tatarsky I, Hochberg Z. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J Clin Invest 1988 ; 81 : 791-7.
51. Merchav S, Lake M, Skottner A, Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II. J Cell Physiol 1993 ; 157 : 178-83.
52. Kurtz A, Zap J, Eckardt KU, Clemons G, Froesch ER, Bauer C. Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Physiol Sci 1988 ; 85 : 7825-9.
53. Murphy WJ, Durum SK, Longo DL. Differential effects of growth hormone and prolactin on murine T cell development and function. J Exp Med 1993 ; 178 : 231-6.
54. Li YM, Brunke DL, Dantzer R, Kelley KW. Pituitary epithelial cell implants reverse the accumulation of CD4- CD8- lymphocytes in thymus glands of aged rats. Endocrinology 1992 ; 130 : 2703-9.
55. Dardenne M, Savino W. Neuroendocrine circuits controlling the physiology of the thymic epithelium. Ann NY Acad Sci 1992 ; 650 : 85-90.
56. Timsit, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF, et al. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992 ; 75 : 183-8.
57. Kimata H, Yoshida A. Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B-cells. J Clin Endocrinol Metab 1994 ; 78 : 635-41.
58. Geffner ME, Bersch N, Golde DW. Insulin and IGF-I stimulate transformed T-lymphocyte cell growth in vitro. Brain Behav Immun 1992 ; 6 : 377-86.
59. Balducci R, Toscano V, Pasquino AM, Anselmi M, Mangiantini A, et al. Lymphocyte subsets in adults with panhypopituitarism before and during GH treatment. Proceeding of the 76th Annual Meeting of the Endocrinology Society ; abstract 276, 1994
60. Khosraviani M, Davis SL. Prolactin (PRL) growth hormone (GH), insulin-like growth hormone (IGF-1) and glucocorticoid (GC) on resting and activated peripheral blood mononuclear (PBMN) cells in sheep. 76th Annual Meet Endocr Soc; abstract 579, 1994
61. Fu YK, Arkins SGF, Cunningham C, Wells JA, Fong S. Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J Clin Invest 1992 ; 89 : 451-7.
62. Edwards III CK, Ghiasuddin SM, Schepper JM, Yunger L, Kelley KA. A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. Science 1988 ; 239 : 769-71.
63. Edwards III CK, Yunger LM, Lorence RM, Dantzer R, Kelley KW. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Immunology 1991 ; 88 : 2274-7.
64. Rovensky J, Vigas M, Lokaj J, Cuncik P, Lukac P, Takac A. Effect of growth hormone on the metabolic activity of phagocytes of peripheral blood in pituitary dwarfs and acromegaly. Endocrinol Exp (Bratisl). 1982 ; 16 : 129-34.
65. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, et al. Differential impact of age, sex, steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 1995 ; 80 : 3209-22.
66. Kern W, Dodt C, Born J, Fehm HL. Changes in cortisol and growth hormone secretion during nocturnal sleep in the course of aging. J Gerontol Ser A Biol Med Sci 1996 ; 51 : M3-M9.
67. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. GHRH 1-29 twice daily reverses the decreased GH and IGF-I levels in old men. J Clin Endocrinol Metab 1992 ; 75 : 530-5.
68. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991 ; 73 : 1081-8.
69. Van Coeverden A, Mockel J, Laurent E, Kerkhofs M, L'Hermite Baleriaux M, De Coster C et al. Neuroendocrine rythms and sleep in aging men. Am J Physiol 1991 ; 260 : E651-61.
70. Rudman D, Vintner MH, Rogers CM, Lubin MF, Flemming GH, Raymond PB. Impaired growth hormone secretion in the adult population. Relation to age and adiposity. J Clin Invest 1981 ; 67 : 1361-9.
71. Bando H, Zhang C., Takada Y, Yamasaki R, Saito S. Impaired secretion of growth hormone -releasing hormone and IGF-I in elderly men. Acta Endocrinol 1991 ; 124 : 31-6.
72. Iovino M, Monteleone P, Steardo L. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. J Clin Endocrinol Metab 1989 ; 69 : 910-3.
73. Ghigo E, Coffi S, Nicolasi M, Arvat E, Valente F, Mazza E, et al. Growth hormone (GH) responsiveness to combined administration of arginine and GH releasing hormone does not vary with age in man. J Clin Endocrinol Metab 1990 ; 71 : 1481-5.
74. Coiro V, Volpi R, Cavazzini V, Bertoni P, Corsadi A, Bianconi L, et al. Restoration of normal growth hormone responsiveness to GHRH in normal aged men by infusion of low amounts of theophylline. J Gerontol 1991 ; 46 : M155-8.
75. Deslauriers N, Gaudreau P, Abribat T, Renier G, Petitclerc D, Brazeau P. Dynamics of growth hormone responsiveness to growth hormone releasing factor in aging rats: peripheral and central influences. Neuroendocrinology 1991 ; 53 : 439-41.
76. Pavlov EP, Harman SM, Merriam GR, Gelato MC, Blackman MR. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986 ; 62 : 595-600.
77. Pyka G, Wiswell RA, Marcus R. Age dependant effect of resistance excercice on growth hormone secretion in people. J Clin Endocrinol Metab 1992 ; 75 : 404-7.
78. Hakkinen K, Pakarinen A. Acute hormonal respnses to heavy resistance exercice in men and women at different ages. Int J Sports Med 1995 ; 16 : 507-13.
79. Hindmarcsh PC, Fall CH, Pringle PJ, Osmond C, Brook CG. Peak and through growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters. J Clin Endocrinol Metab 1997 ; 82 : 2172-6.
80. Hattori N, Kurahachi H, Ikebo K, Ishira T, Moridera K, Hino M, et al. Effects of sex and age on serum GH binding protein levels in normal adults? Clin Endocrinol 1991 ; 35 : 295-7.
81. Maheshwari H, Sharma L, Baumann G. Decline of plasma growth hormone binding protein in old age. J Clin Endocrinol Metab 1996 ; 81 : 995-8.
82. Rudman D, Mattson DE. Serum Insulin-Like Growth Factor I in healthy older men in relation to physical activity. J Am Geriatr Soc 1994 ; 42 : 71-6.
83. Poehlman ET, Copeland KC. Influence of physical activity on insulin-like growth factor I in healthy younger and older men. J Clin Endocrinol Metab 1990 ; 71 : 1468-73.
84. Yamamoto H, Sohmiya M, Oka N, Kato Y. Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol 1991 ; 124 : 497-500.
85. Rudman D. Growth hormone, body composition and aging. Am J Geriatr Soc 1985 ; 33 : 800-7.
86. Paolisso G, Ammendola S, del Buono A, Gambardelle A, Riondino M, Tagliamote MR, et al. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 1997 ; 82 : 2204-9.
87. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, et al. Serum insulin-like growth factor I in a ramdom population sample of men and women: relation to age, sex, smoking habits, coffee consomption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormones and osteocalcine. Clin Endocrinol 1994 ; 41 : 351-7.
88. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocrinol Rev 1993 ; 14 : 20-39.
89. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997 ; 145 : 970-6.
90. Ceda GP, Dall'Aglio E, Magnacavallo A, Fontana V, Maggio M, Valenti G, et al. The insulin-like growth factor axis and plasma lipid levels in the ederly. J Clin Endocrinol Metab 1998 ; 83 : 499-502.
91. Bonnefoy M, Kostka T, Patricot MC, Berthouze SE, Mathian B, Lacour JR. Physical activity and dehydroepiandrosterone sulphate, insulin-like growth factor I and testosterone in healthy active elderly people. Age and Ageing 1998 ; 27 : 745-51.
92. Copeland KC, Colletti RB, Devlin JD, Mc Auliffe TL. The relationship between insulin-like growth factor I, adiposity, and aging. Metabolism 1990 ; 39 : 584-7.
93. Xu X, Sonntag WE. Growth hormone and the biology of aging. In: Mobbs CV, Hof PR, eds. Functional Endocrinoogy of aging. Basel : Karger Press ; 1998. p. 67-88.
94. Baxter RC, Martin JL. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986 ; 78 : 1504-12.
95. Frost RA, Fuhrer J, Steigbigel R, Mariuz P, Lang CH, Gelato MC. Wasting in the AIDS syndrome is associated with multiple defects in the serum IGF system. Clin Endocrinol (Oxf) 1996 ; 44 : 501-14.
96. Benbassat CA, Maki KC, Unterman TG. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationship to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 1997 ; 82 : 1484-91.
97. Rutanen EM, Kerkkaninen T, Stenmen VH, Yki-Jarvinen H. Aging associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J Clin Endocrinol Metab 1993 ; 77 : 1152-5.
98. Nystrom FH, Ohman PK, Ekman BA, Osterlund MK, Karlberg BE, Arnqvist HJ. Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropometric variables. Eur J Endocrinol 1997 ; 136 : 165-72.
99. Rosen CJ, Conover C. Growth hormone/Insulin-like growth factor-I axis in aging: a summary of a national institutes of aging sponsored symposium. J Clin Endocrinol Metab 1997 ; 82 : 3919-22.
100. Mohan S, Farley JR, Baylink DJ. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implicat ions for bone loss with aging. Prog Growth Factors Res 1995 ; 6 : 465-73.
101. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PWF, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the fragmingham heart study. J Clin Endocrinol Metab 1998 ; 83 : 4257-62.
102. Sun YK, Xi YP, Fenoglio CM, Pushparaj N, O'Toole M, Kledizik GS, et al. The effect of age on number of pituitary cells immunoreactive to growth hormone and prolactin. Hum Pathol 1984 ; 15 : 169-80.
103. Calderon L, Ryan N, Kovacks K. Human pituitary growth hormone cells in old age. J Gerontol 1978 ; 24 : 441-7.
104. Ceda GP, Valenti G, Buitturini V. Diminished pituitary responsivness to growth hormone-releasing factor in aging male rats. Endocrinology 1986 ; 118 : 2109-14.
105. Veldhuis JD, Iranmanesh A, Weltman A. Elements in the pathophysiology of diminished growth hormone (GH) secretion in aging humans. Endocrine 1997 ; 7 : 41-8.
106. Kelijman M. Age-related alterations of growth hormone/ insulin-like growth factor I axis. Am J Geriatr Soc 1991 ; 39 : 295-307.
107. De Gennaro Colonna V, Zoli M, Cocchi D, Maggi A, Marrama P, Agnaki LF et al. Reduced growth hormone releasing factor (GHRH)-like immuno reactivity and GHRH gene expression in hypothalamus of aged rats. Peptides 1989 ; 10 : 705-9.
108. Sonntag WE, Hylka VW, Meites J. Impaired ability of old male rats to secrete growth hormone in vivo but not in vitro in response to hp GRF (1-44). Endocrinology 1983 ; 113 : 2305-7.
109. Sonntag WE, Gottschall PE, Meites J. Increased secretion of somatostatin-28 from hypothalamic neurons of aged rats in vitro. Brain Res 1986 ; 380 : 229-31.
110. Spik K, Sonntag WE. Increased pituitary response to somatostatin in aging male rat: relationship to somatostatin receptor number and affinity. Neuroendocrinology 1989 ; 50 : 489-92.
111. Hagberg J, Seals D, Yerg E. Metabolic responses to exercise in young and older athletes and sedentary men. J Appl Physiol 1988 ; 65 : 900-8.
112. Kiel DP, Puhl J, Rosen CJ, Berg K, Murphy JB, MacLean DB. Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with fucntional limitations. J Am Geriartr Soc 1998 ; 46 : 822-8.
113. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wuster C, et al. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 1996 ; 81 : 2534-40.
114. Hartman ML, Pezzoli S, Hellmann PJ, Suratt PM, Thorner MO. Pulsatile growth hormone secretion in older personne is enhanced by fasting without relationship to sleep stages. J Clin Endocrinol Metab 1996 ; 81 : 2694-701.
115. Kaplan SL. The newer use of growth hormone in adults. Adv Intern Med 1993 ; 38 : 287-301.
116. Rosen CJ, Donaline LR. Insulin like growth factors potential therapeutic options for osteoporosis. TEM 1995 ; 6 : 235-41.
117. Rosen CJ. Growth hormone, Insulin-Like Growth Factors and the senescent skeleton: Ponce de Leon's Fountain revisited. J Cell Biochem 1994 ; 56 : 348-56.
118. Nicolas V, Prewett A, Bettica P, Mohans S, Finkelman RD, Baylink DJ, et al. Age related decreases in Insulin-Like Growth Factor-I and Transforming Growth Factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 1994 ; 78 : 1011-6.
119. Boonen S, Aerssens J, Broos P, Pelemans W, Dequeker J. Age-related bone loss and senile osteoporosis : Evidence for both secondary hyperthyroidism and skeletal growth factor deficiency in the ederly. Aging Clin Exp Res 1995 ; 7 : 414-22.
120. Rosen CJ, Donahue LR, Hunter SJ, Musgrave KO, Chen T, Wen-Wei W, et al. The 24/25 kDa serum IGFBP is increased in elderly womenwith hip and spine fractures. J Clin Endocrinol Metab 1992 ; 74 : 24-7.
121. Hamilton MT, Marsh DR, Criswell DS, Lou W, Booth FW. No effect of aging on skeletal muscle insulin-like growth factor mRNA. Am J Physiol 1995 ; 38 : R1183-8.
122. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, et al. Effect of recombinant hGH on the muscle strength in older men. J Clin Endocrinol Metab 1994 ; 79 : 1361-6.
123. Taafe CR, Jin IH, Vu TH, Hoffman AR, Marcus R. Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men. J Clin Endocrinol Metab 1996 ; 81 : 421-5.
124. Welle S, Thornton C, Statt M, Mc Henry B. Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endocrinol Metab 1996 ; 81 : 3239-43.
125. Toogood AA, Shalet SM. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study. J Clin Endocrinol Metab 1999 ; 84 : 131-6.
126. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserves the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991 ; 72 : 51-9.
127. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW. Serum total IGF-I, free IGF-I and IGFBP-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vase Biol 1998 ; 18 : 277-82.
128. Serri O, St-Jacques P, Sartippour M, Renier G. Alterations of monocyte function in patients with growth hormone (GH) deficiency : effect of substitutive GH therapy. J Clin Endocrinol Metab 1999 ; 84 : 58-63.
129. Kelley KW. Growth hormone, lymphocytes and macrophages. Biochem Pharmacol 1989 ; 38 : 705-13.
130. Khansari DN, Gustad T. Effects of long-term, low-dose growth hormone therapy on immune function and life expectancy of mice. Mech Ageing Dev 1991 ; 57 : 87-100.
131. Goff BL, Roth JA, Arp LH, Incefy GS. Growth hormone treatement stimulates thymulin production in aged dogs. Clin Exp Immunol 1987 ; 68 : 580-7.
132. Goya RG, Gagnerault M, De Morales MC, Savino W, Dardenne M. In vivo effects of growth hormone on thymus function in aging mice. Brain Behav Immun 1992 ; 6 : 341-54.
133. 3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Aca Sci USA 1986 ; 83 : 5663-7.
134. Bonello RS, Marcus R, Bloch D, Stober S. Effects of growth hormone and estrogen on T lymphocytes in older women. J Am Geriatr Soc 1996 ; 44 : 1038-42.
135. Muller EE, Cella SG, Degennaro Colonna B, Parenti M, Cocchi D, Locatelli V. Aspects of the neuroendocrine control of growth hormone secretion in ageing mammals. J Reprod Fert 1993 ; suppl 46 : 99-114.
136. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg A, et al. Effects of human growth hormone in men over 60 years. N Engl J Med 1990 ; 323 : 1-6.
137. Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DI, Hintz RL, et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990 ; 70 : 519-27.
138. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly women. J Clin Endocrinol Metab 1994 ; 79 : 470-9.
139. Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM. Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol 1995 ; 268 : E268-76.
140. Cuttica CM, Castoldi L, Gorrini GP, Peluffo F, Delitala G, Filippa P, et al. Effects of six month administration of recombinant human growth hormone to healthy elderly subjects. Aging Clin Exp Res 1997 ; 9 : 193-7.
141. Thompson JL, Butterfield GE, Marcus R, Hintz RL, Vorn Loan M, Gihron L, et al. The effects of recombinant human insulin like growth factor-1 and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 1995 ; 80 : 1845-52.
142. Papadakis MA, Grady D, Black D. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Int Med 1996 ; 124 : 708-16.
143. Lamberts SWJ, Van den Beld AW, Van der Lely AJ. The endocrinology of aging. Science 1997 ; 278 : 419-24.
144. Eriksen EF, Kassem M, Brixen K. Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis. Horm Res 1993 ; 40 : 95-8.
145. Johansson AG, Lindh E, Blum WF, Kollerrup G, Sorensen OH, Ljunghall S. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1996 ; 81 : 44-8.
146. Butterfield GE, Thompson J, Rennie MJ, Marcus R, Hintz RL, Van Loan M, et al. Effect of rhGH and rhIGF-1 treatment on protein utilization in elderly women. Am J Physiol 1997 ; 272 : E94-9.
147. Binnerts A, Wilson JH, Lamberts SW. The effects of human growth hormone administration in elderly adults with recent weight loss. J Clin Endocrinol Metab 1988 ; 67 : 1312-6.
148. Kaiser FE, Silver AJ, Morley JE. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriat Soc 1991 ; 39 : 235-340.
149. Guistina A, Bussi AR, Jacobello C, Weheznberg WB. Effects of recombinant human growth (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endotenous GH response to GH-releasing hormone. J Clin Endocrinol Metab 1995 ; 80 : 122-9.
150. Pichard C, Kyle U, Chevrolet JC. Lack of effect of recombinant human growth hormone in patients requiring prolonged mechanical ventilation: a prospective randomized, controlled study. Crit Care Med 1996 ; 24 : 403-13.
151. Sullivan DH, Carter WJ, Warr WR, Williams LH. Side effects resulting from the use of growth hormone and insulin-like growth factor-1 as combined therapy to frail elderly patients. J Gerontol AB Biol Sci Med Sci 1998 ; 53 : M183-7.
152. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, MA J, Wilkinson P, et al. Plasma insulin-like growth factor 1 and prostate cancer risk: a prospective study. Science 1998 ; 279 : 563-6.
153. Vittone J, Blackman MR, Whitehead JB, Tsiao C, Stewart KJ, Tobin J, et al. Effects of single nightly injections of growth hormone releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism 1997 ; 46 : 89-96.
154. 2 in age-advanced men and women. J Clin Endocrinol Metab 1997 ; 82 : 1472-9.
155. Borst SE, Millward WJ, Lowenthal DT. Growth hormone, exercice and aging: the future of therapy for the frail elderly. J Am Geriatr Soc 1994 ; 42 : 528-35.
156. Fiatarone MA, O'Neill EF, Ryan DN, Clements KM, Solares GR, Nelson ME, et al. Exercice training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994 ; 330 : 1769-75.
157. Hurson M, Regan MC, Kirk SJ, Wasserkrug HL, Barbul A. Metabolic effects of arginine in a healthy elderly population. J Parenter Enteral Nutr 1995 ; 19 : 227-30.
158. Jeevanandam M, Ali MR, Petersen SR. Substrate and hormonal changes due to dietary supplementation with ornithine α-ketoglutarate (OKG) in critically ill trauma victims. Clin Nutr 1992 ; 11 suppl 26.
159. Lanzi R, Pontiroli AE. Growth hormone treatment for the elderly? Aging Clin Exp Res 1992 ; 4 : 179-81.